Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 566

1.

Apocrine adenoma of the breast coexistent with invasive carcinoma.

Bezić J, Forempoher G, Poljicanin A, Gunjaca G.

Pathol Res Pract. 2007;203(11):809-12.

PMID:
17936522
2.

Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.

Tramm T, Kim JY, Tavassoli FA.

Am J Surg Pathol. 2011 Feb;35(2):202-11. doi: 10.1097/PAS.0b013e31820598a2.

PMID:
21263240
3.

A case of sebaceoma with extensive apocrine differentiation.

Tanahashi J, Kashima K, Daa T, Kondoh Y, Yada N, Kuratomi E, Yokoyama S.

Am J Dermatopathol. 2008 Aug;30(4):408-11. doi: 10.1097/DAD.0b013e31817d2a4a.

PMID:
18645320
5.

Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.

Vazmitel M, Michal M, Mukensnabl P, Kazakov DV.

Am J Dermatopathol. 2008 Feb;30(1):51-3. doi: 10.1097/DAD.0b013e31815c4cf4.

PMID:
18212545
6.

Three-millimeter apocrine adenoma in a man: a case report and review of the literature.

Pasquale-Styles MA, Milikowski C.

Arch Pathol Lab Med. 2003 Nov;127(11):1498-500. Review.

PMID:
14567753
7.

Spiradenocarcinoma of the breast arising in a long-standing spiradenoma.

Ribeiro-Silva A, Shaletich C, Careta RS, Kazava DK, Siqueira MC, Ponton F.

Ann Diagn Pathol. 2004 Jun;8(3):162-6.

PMID:
15185264
8.

An unusual tumor of the female breast: combined eccrine and apocrine spiradenoma.

Zawirska B, Cisek T, Markuszewska-Bednarz J.

Patol Pol. 1983 Jan-Mar;34(1):125-8. No abstract available.

PMID:
6310473
10.
11.
12.

Carcinoma ex spiradenoma/cylindroma confirmed by immunohistochemical and molecular loss-of-heterozygosity profiling.

Jukic DM, Drogowski LM, Davie JR.

Am J Dermatopathol. 2009 Oct;31(7):702-8. doi: 10.1097/DAD.0b013e3181a6b6f4.

PMID:
19684510
13.
14.

Pure or mixed-type invasive lobular carcinoma?

Bulut N, Dede DS, Sari E, Altundag K.

Hum Pathol. 2008 Jul;39(7):1121; author reply 1121. doi: 10.1016/j.humpath.2008.04.002. No abstract available.

PMID:
18570979
15.

Apocrine adenoma of the breast.

Cashell AW.

W V Med J. 2008 Mar-Apr;104(2):16-9.

PMID:
18491794
16.

A case of ductal sweat gland carcinoma connected to syringocystadenoma papilliferum arising in nevus sebaceus.

Ansai S, Koseki S, Hashimoto H, Hozumi Y, Kondo S.

J Cutan Pathol. 1994 Dec;21(6):557-63.

PMID:
7699123
17.

Adenocarcinoma in situ arising in a tubulopapillary apocrine hidradenoma of the peri-anal region.

Obaidat NA, Awamleh AA, Ghazarian DM.

Eur J Dermatol. 2006 Sep-Oct;16(5):576-8.

PMID:
17101482
18.

Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas.

Busam KJ, Tan LK, Granter SR, Kohler S, Junkins-Hopkins J, Berwick M, Rosen PP.

Mod Pathol. 1999 Aug;12(8):786-93.

PMID:
10463481
19.

Tubular apocrine adenoma in association with syringocystadenoma papilliferum.

Aktepe F, Demir Y, Dilek FH.

Dermatol Online J. 2003 Feb;9(1):7.

20.

Eccrine syringofibroadenoma of clear cell variant: an immunohistochemical study.

Hu S, Bakshandeh H, Kerdel FA, Rongioletti F, Romanelli P.

Am J Dermatopathol. 2005 Jun;27(3):228-31.

PMID:
15900127

Supplemental Content

Support Center